Aranda A, Soto V

Language: Spanish
References: 13
Page: 334-337
PDF size: 78.14 Kb.

ABSTRACT

Myocardiopathies are myocardial diseases of unknown origin, consisting of a mixture of gene and acquired factors distinctive anatopathological varieties and super imposition of its natural history and functional patterns. Future treatment involves, besides cardiac and cellular grafts, as well as gene transfer for repopulation and for myocardial cellular regeneration.

REFERENCES

1. Watson JD, Crick FHC: Molecular structure of Nucleic Acids. Rev Invest Clin 2003; 55(2): 108-109.

2. Woo A, Rakowski H, Liew JC, Zhao MS, Liew CC, Parker TG: Mutations of beta myosin heavy chain gene in hypertrophic cardiomyopathy, critical functional sites, determine prognosis. Heart 2003; 89(10): 1179-85.

3. Yue Y, Li Z, Harper SQ, Davisson RL, Chamberlain JS, Duan D: Microdystrophin gene therapy of cardiomyopathy, restores dystrophin-glycoprotein complex, and improves sarcolemma integrity in the mdx mouse heart. Circulation 2003; 108(13): 1626-32.

4. Moolman-Smook JC, Mayosi BM, Brink PA, Corfield VA: Molecular genetics of cardiomyopathy: changing times, shifting paradigms. Cardiovasc J S Afr 2003; 14(3): 145-55.

5. Bonnet D: Role of molecular biology in understanding the formation of congenital cardiomyopathies in humans. J Soc Biol 2003; 197(2): 195-9.

6. Mc Kenna WJ, Stewart JT, Nohoyannopoulos P: Hipertrophic cardiomyopathy without hypertrophy. Two families with myocardial disarray in the absence of increased myocardial mass. Br Heart J 1990; 63: 287.

7. Hina K, Kusachi S, Iwasaki K: Progression of left ventricular enlargement in patients with hypertrophic cardiomyopathy: Incidence and prognostic value. Clin Cardiol 1993; 16: 403.

8. Burch GE, Giles TD, Colcolough HL: Ischemic cardiomyopathy. Am Heart J 1970; 83: 340.

9. Pfeffer MA, Braunwald E: Ventricular remodeling after myocardial infarction. Circulation 1990; 81: 1161.

10. Richardson P, Mc Kenna W, Bristow M, et al: Report of the 1995 World Health Organization/International Society and Federation of Cardiology task force on the definition and classification of cardiomyopathies. Circulation 1996; 93: 841.

11. Prieto Gallo, Giulia d´Amati: Cardiomyopathies. Silver, Gotileb, Schoen. Cardiovascular Pathology. Third edition. Philadelphia. Churchill Livingstone. 2001: 285-325.

12. Firoozi S, Sharma S, McKenna WJ: Risk of competitive sport in young athletes with heart disease. Hearth 2003; 89(7): 710-4.

13. Anversa P, Nadal-Girard B: Myocite renewal and ventricular remodeling. Nature 2002; 415(10): 234-9.